These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26391556)

  • 21. [Automated system of mass examination of the working population].
    Maslennikov OV; Androsov SV; Araten SM; Gorbunova NA; Grachev VIu; Marychev SIu; Minchenko IA; Novikova AG; Panov AG; Sazanova TI
    Sov Zdravookhr; 1991; (6):42-5. PubMed ID: 1835145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk assessment for prevention of morbidity and mortality: lessons for pressure ulcer prevention.
    Reynolds TM
    J Tissue Viability; 2008 Nov; 17(4):115-20. PubMed ID: 19061825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Close-Call Screening and Shared Decision Making.
    Chan E
    AMA J Ethics; 2015 Jul; 17(7):601-7. PubMed ID: 26158806
    [No Abstract]   [Full Text] [Related]  

  • 24. [Recommendations for prevention and evidence-based medicine].
    Gohlke H; Schuler G
    Z Kardiol; 2005; 94 Suppl 3():III/1-5. PubMed ID: 16258784
    [No Abstract]   [Full Text] [Related]  

  • 25. Principles behind practice. 8. Screening as a strategy for disease control.
    Mitchell H; Irwig L
    Med J Aust; 1991 Aug; 155(4):237-9, 242. PubMed ID: 1875838
    [No Abstract]   [Full Text] [Related]  

  • 26. Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Methodologic considerations for preventing Alzheimer's disease by 2020.
    Shankle WR
    Alzheimers Dement; 2010 Mar; 6(2):145-6. PubMed ID: 20298977
    [No Abstract]   [Full Text] [Related]  

  • 27. Understanding and communicating risk: Measures of outcome and the magnitude of benefits and harms.
    Bell NR; Dickinson JA; Grad R; Singh H; Kasperavicius D; Thombs BD
    Can Fam Physician; 2018 Mar; 64(3):181-185. PubMed ID: 29540382
    [No Abstract]   [Full Text] [Related]  

  • 28. [Risk evaluation, disease prophylaxis, life insurance].
    Fehér J; Horváth I
    Orv Hetil; 2008 Apr; 149(15):675-6. PubMed ID: 18387870
    [No Abstract]   [Full Text] [Related]  

  • 29. Screening for dementia: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am J Nurs; 2003 Sep; 103(9):87, 89, 91, 93, 95. PubMed ID: 14501480
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk Calculators and Decision Aids Are Not Enough for Shared Decision Making.
    Kopecky KE; Urbach D; Schwarze ML
    JAMA Surg; 2019 Jan; 154(1):3-4. PubMed ID: 30326000
    [No Abstract]   [Full Text] [Related]  

  • 31. Principles of screening.
    Nielsen C; Lang RS
    Med Clin North Am; 1999 Nov; 83(6):1323-37, v. PubMed ID: 10584597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detecting women at risk for postpartum mood disorders.
    McDowell WK
    Nursing; 2008 Mar; 38(3):57-8. PubMed ID: 18418187
    [No Abstract]   [Full Text] [Related]  

  • 33. [TalkingEyes-and-more].
    Michelson G
    Biomed Tech (Berl); 2005; 50(7-8):218-26. PubMed ID: 16117435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantifying the benefits and harms of various preventive health activities.
    Ewald B; Del Mar C; Hoffmann T
    Aust J Gen Pract; 2018 Dec; 47(12):842-845. PubMed ID: 31212401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using the question-behavior effect to promote disease prevention behaviors: two randomized controlled trials.
    Conner M; Godin G; Norman P; Sheeran P
    Health Psychol; 2011 May; 30(3):300-9. PubMed ID: 21553974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary Aldosteronism: unnecessary complexity in definition and diagnosis as a barrier to wider clinical care.
    Kline GA
    Clin Endocrinol (Oxf); 2015 Jun; 82(6):779-84. PubMed ID: 25891981
    [No Abstract]   [Full Text] [Related]  

  • 37. Early detection of the need for intensive care.
    Gordo Vidal F; Abella Álvarez A
    Emergencias; 2018 Oct; 30(5):350-353. PubMed ID: 30260120
    [No Abstract]   [Full Text] [Related]  

  • 38. Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies?
    Cetin I; Huppertz B; Burton G; Cuckle H; Gonen R; Lapaire O; Mandia L; Nicolaides K; Redman C; Soothill P; Spencer K; Thilaganathan B; Williams D; Meiri H
    Placenta; 2011 Feb; 32 Suppl():S4-16. PubMed ID: 21185077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoporosis prevention through screening: will it be cost effective?
    Torgerson DJ; Reid DM
    Baillieres Clin Rheumatol; 1993 Oct; 7(3):603-22. PubMed ID: 8293493
    [No Abstract]   [Full Text] [Related]  

  • 40. Part II: Basic approach to health screening.
    Swee DE; Micek-Galinat L
    N J Med; 1991 Jul; 88(7):487-91. PubMed ID: 1891126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.